Agree 1
controlled trial · 2019 · landmark · cited on tape
“However, metformin prevented gains in lean mass with PRT (between groups p = .003); placebo gained 1.95% ( SD 2.69) lean mass ( p < .001), while the 0.41% change ( SD 2.25) in metformin did not reach significance ( p = .218) (Figure 2 b; Appendix S2 : Table 2 ).”
Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial. Aging Cell
Who: 109 healthy, nondiabetic, community-dwelling adults aged 65 and over (median age 69.3, 56% female) in Kentucky and Alabama; 94 completed
PMID 31557380
Partly agree 3
other primary study · 2022
“In contrast, statin users randomized to metformin demonstrated a significantly higher increase in fiber cross-sectional area (fCSA) compared to metformin alone (MET vs. MET + STAT, p = 0.002), with significant growth occurring in both fiber types.”
Potential Benefits of Combined Statin and Metformin Therapy on Resistance Training Response in Older Individuals. Front Physiol
Who: 94 healthy older adults aged 65 or more who completed the MASTERS trial, split by statin use: placebo only 34, statin only 14, metformin only 29, metformin plus statin 17
PMID 35492586
trial or observed group · 2012
“Metformin increased FFM in adolescent girls treated during puberty ( 23 ), but in the current study, FFM was unaffected by metformin and slightly higher after training alone.”
Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care
Who: 32 otherwise healthy, nonsmoking men and women with impaired glucose tolerance (prediabetes) from the local community, Amherst, Massachusetts
PMID 22040838
trial or observed group · 2021
“Our primary outcomes report from the MASTERS trial showed that, compared to placebo, metformin blunts hypertrophy, strength, and normal muscle density gains following PRT [54].”
Associations of muscle lipid content with physical function and resistance training outcomes in older adults: altered responses with metformin. Geroscience
Who: 94 healthy, moderately active older adults aged >=65 (mean 70.4 y, 54% female, 98% Caucasian) completing progressive resistance training in the MASTERS trial
PMID 33462708